Drug Shortage Report for DEPO-TESTOSTERONE INJ 100MG/ML

Last updated on 2023-05-03 History
Report ID 134289
Drug Identification Number 00030783
Brand name DEPO-TESTOSTERONE INJ 100MG/ML
Common or Proper name DEPO-TESTOSTERONE
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) TESTOSTERONE CYPIONATE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10mL vial
ATC code G03BA
ATC description ANDROGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-05
Estimated end date 2023-05-15
Actual end date 2023-05-02
Shortage status Resolved
Updated date 2023-05-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2023-05-03 French Compare
v12 2023-05-03 English Compare
v11 2023-04-21 French Compare
v10 2023-04-21 English Compare
v9 2021-12-10 French Compare
v8 2021-12-10 English Compare
v7 2021-07-06 English Compare
v6 2021-07-05 French Compare
v5 2021-07-05 English Compare
v4 2021-06-02 French Compare
v3 2021-06-02 English Compare
v2 2021-02-17 French Compare
v1 2021-02-17 English Compare

Showing 1 to 13 of 13